Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Radiol Case Rep ; 19(7): 2735-2740, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38680743

ABSTRACT

This case report delves into the intricate diagnostic journey of a 42-year-old male presenting with jaundice, abdominal distension, and ascites, where medical imaging, including CT scans and ultrasound, played a central role. Noteworthy radiological findings, such as irregular nodular margins and caudate lobe hypertrophy, illuminated the distinctive pathophysiology of cryptogenic cirrhosis. The study underscores the pivotal role of medical imaging in elucidating complex liver pathologies, emphasizing the relevance of radiological approaches in diagnosing cryptogenic cirrhosis and guiding comprehensive management strategies.

2.
Cureus ; 16(2): e54069, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38481885

ABSTRACT

Arsenic is a natural element found in the earth's crust and is extensively present in various environmental components. Anthropogenic activities and a few natural events have generated contaminants that have led to massive environmental pollution, one form of which is arsenic contamination. Arsenic enters the human food chain via contaminated crops, water, seafood, and dairy products. In Pakistan, the increasing concentration of arsenic in the water is causing major health problems. Due to the serious health risks posed by arsenic, it is crucial to design and implement strategies for reducing and preventing the bioaccumulation of arsenic and its entry into the human food chain. There is a need for an institutional framework for arsenic mitigation, accountability, and systemic checks and balances. Targeted short- and long-term policies are required for effective and sustainable management.

3.
Lancet Glob Health ; 8(4): e555-e566, 2020 04.
Article in English | MEDLINE | ID: mdl-32199123

ABSTRACT

BACKGROUND: An estimated 5·1 million stillbirths and neonatal deaths occur annually. Household surveys, most notably the Demographic and Health Survey (DHS), run in more than 90 countries and are the main data source from the highest burden regions, but data-quality concerns remain. We aimed to compare two questionnaires: a full birth history module with additional questions on pregnancy losses (FBH+; the current DHS standard) and a full pregnancy history module (FPH), which collects information on all livebirths, stillbirths, miscarriages, and neonatal deaths. METHODS: Women residing in five Health and Demographic Surveillance System sites within the INDEPTH Network (Bandim in Guinea-Bissau, Dabat in Ethiopia, IgangaMayuge in Uganda, Matlab in Bangladesh, and Kintampo in Ghana) were randomly assigned (individually) to be interviewed using either FBH+ or FPH between July 28, 2017, and Aug 13, 2018. The primary outcomes were stillbirths and neonatal deaths in the 5 years before the survey interview (measured by stillbirth rate [SBR] and neonatal mortality rate [NMR]) and mean time taken to complete the maternity history section of the questionnaire. We also assessed between-site heterogeneity. This study is registered with the Research Registry, 4720. FINDINGS: 69 176 women were allocated to be interviewed by either FBH+ (n=34 805) or FPH (n=34 371). The mean time taken to complete FPH (10·5 min) was longer than for FBH+ (9·1 min; p<0·0001). Using FPH, the estimated SBR was 17·4 per 1000 total births, 21% (95% CI -10 to 62) higher than with FBH+ (15·2 per 1000 total births; p=0·20) in the 5 years preceding the survey interview. There was strong evidence of between-site heterogeneity (I2=80·9%; p<0·0001), with SBR higher for FPH than for FBH+ in four of five sites. The estimated NMR did not differ between modules (FPH 25·1 per 1000 livebirths vs FBH+ 25·4 per 1000 livebirths), with no evidence of between-site heterogeneity (I2=0·7%; p=0·40). INTERPRETATION: FPH takes an average of 1·4 min longer to complete than does FBH+, but has the potential to increase reporting of stillbirths in high burden contexts. The between-site heterogeneity we found might reflect variations in interviewer training and survey implementation, emphasising the importance of interviewer skills, training, and consistent implementation in data quality. FUNDING: Children's Investment Fund Foundation.


Subject(s)
Infant Mortality , Stillbirth/epidemiology , Surveys and Questionnaires , Adolescent , Adult , Bangladesh/epidemiology , Ethiopia/epidemiology , Female , Ghana/epidemiology , Guinea-Bissau/epidemiology , Humans , Infant , Infant, Newborn , Middle Aged , Reproducibility of Results , Uganda/epidemiology , Young Adult
4.
Mar Pollut Bull ; 136: 22-32, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30509802

ABSTRACT

We investigated the bioavailability, mobility, and origin of heavy metals present in sediments from the Anzali Wetland. Chemical speciation of the metals was performed according to the Tessier method. Results indicated that Cd and As showed the highest level of bioavailability, whereas Cr showed the lowest level. Cr, Co, and V were shown to have a terrestrial origin. The metal As was mostly found in the reducible fraction (F3), whereas other metals were highest in the residual phase. The levels of Co present in the oxidizable fraction (F4); Pb and Cd present in the carbonate fraction (F2); and the other metals present in the exchangeable fraction (F1) were found to be the lowest. On the basis of the Risk Assessment Code of metals, Cd at most stations, As and Ni at some stations, and Zn at one station revealed to have a moderate risk. Co and Pb were found to have a low risk at all stations. Considering Pollution Load Index, stations 2 and 3 were classified as moderately polluted and the remaining stations were unpolluted. As suggested by enrichment factor analysis, As was moderately enriched and other metals had a deficiency to minimal enrichment at all the stations.


Subject(s)
Environmental Monitoring/methods , Geologic Sediments/chemistry , Metals, Heavy/analysis , Water Pollutants, Chemical/analysis , Wetlands , Biological Availability , Caspian Sea , Iran , Risk Assessment
5.
Mol Ther ; 13(2): 374-81, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16337205

ABSTRACT

Treatment of congenital and acquired liver disease is one of the main issues in the field of gene therapy. Self-inactivating lentiviral vectors have several potential advantages over alternative systems. We have constructed a self-inactivating lentiviral vector (LV-ALBUGT) that expresses the human bilirubin UDP-glucuronosyltransferase (UGT1A1) from a liver-specific promoter. UGT1A1 is involved in the clearance of heme metabolites in the liver. This enzyme is deficient in Crigler-Najjar disease, a recessive inherited disorder in humans characterized by chronic severe jaundice, i.e., high plasma bilirubin levels. Gunn rats suffer from the same defect and are used as an animal model of this disease. We have treated juvenile Gunn rats by single intravenous injection with the LV-ALBUGT vector. Over 1 year after treatment with the highest dose (5 x 10(8) transducing units), we observed a stable reduction of bilirubin levels to near normal levels and normal secretion of bilirubin conjugates in the bile, in contrast to untreated animals. In situ hybridization showed expression of the therapeutic gene in more than 30% of liver parenchymal cells. Thus, we demonstrate stable and complete clinical remission of a congenital metabolic liver disease in an animal model, after systemic administration of a therapeutic lentiviral vector.


Subject(s)
Crigler-Najjar Syndrome/therapy , Genetic Therapy , Genetic Vectors/administration & dosage , Glucuronosyltransferase/administration & dosage , Glucuronosyltransferase/deficiency , Lentivirus/genetics , Liver/virology , Animals , Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/virology , Cell Line , Cell Line, Tumor , Crigler-Najjar Syndrome/enzymology , Crigler-Najjar Syndrome/genetics , Disease Models, Animal , Female , Genetic Therapy/methods , Genetic Vectors/therapeutic use , Glucuronosyltransferase/genetics , Glucuronosyltransferase/therapeutic use , Humans , Injections, Intravenous , Liver/pathology , Male , Mice , Rats , Rats, Gunn
SELECTION OF CITATIONS
SEARCH DETAIL
...